Waldenström’s Macroglobulinemia/Lymphoplasmacytic Lymphoma
- 15 April 2013
- book chapter
- other
- Published by Springer Science and Business Media LLC
Abstract
No abstract availableKeywords
This publication has 117 references indexed in Scilit:
- Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemiaCancer, 2011
- Attainment of complete/very good partial response following rituximab‐based therapy is an important determinant to progression‐free survival, and is impacted by polymorphisms in FCGR3A in Waldenstrom macroglobulinaemiaBritish Journal of Haematology, 2011
- Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signallingNature, 2010
- Identification of Critical Residues of the MyD88 Death Domain Involved in the Recruitment of Downstream KinasesOnline Journal of Public Health Informatics, 2009
- Hepatitis C viral infection is not associated with Waldenström's macroglobulinemiaAmerican Journal of Hematology, 2006
- Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaSeminars in Oncology, 2003
- Acquired immunobullous disease: a cutaneous manifestation of IgM macroglobulinaemiaBritish Journal of Dermatology, 1996
- Case 3-1990The New England Journal of Medicine, 1990
- Biologic Activity of Cold-Reacting AutoantibodiesThe New England Journal of Medicine, 1977
- Biologic Activity of Cold-Reacting AutoantibodiesThe New England Journal of Medicine, 1977